Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Strangfeld

Showing results (51-60 of 131) with videos related to

Pageof 14
Sort By:
Rheumatology International|November 17, 2017
Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohortLisa Baganz, Adrian Richter, Jörn Kekow, et al.
Rheumatology (Oxford, England)|November 21, 2019
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritisMartin Schäfer, Yvette Meißner, Jörn Kekow, et al.
Arthritis Research & Therapy|January 13, 2010
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITAnja Strangfeld, Franka Hierse, Rolf Rau, et al.
Rheumatology (Oxford, England)|February 20, 2020
Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritisMartin Schäfer, Yvette Meißner, Jörn Kekow, et al.
Rheumatology (Oxford, England)|May 24, 2015
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBITKerstin Gerhold, Adrian Richter, Matthias Schneider, et al.
Arthritis and Rheumatism|November 1, 2006
Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trialsAngela Zink, Anja Strangfeld, Matthias Schneider, et al.
Arthritis Research & Therapy|August 2, 2023
Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohortAndreas Reich, Anja Weiß, Lisa Lindner, et al.
Arthritis Research & Therapy|October 11, 2024
Correction: Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohortAndreas Reich, Anja Weiß, Lisa Lindner, et al.
RMD Open|April 5, 2024
Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT registerTatjana Rudi, Vera Zietemann, Yvette Meissner, et al.
Annals of the Rheumatic Diseases|April 28, 2021
EULAR COVID-19 registry: lessons learnt and future considerationsSaskia Lawson-Tovey, Anja Strangfeld, Kimme L Hyrich, et al.
Pageof 14

Showing results (51-60 of 131) with videos related to

Sort By:
Pageof 14
Rheumatology International|November 17, 2017
Long-term effectiveness of tocilizumab in patients with rheumatoid arthritis, stratified by number of previous treatment failures with biologic agents: results from the German RABBIT cohortLisa Baganz, Adrian Richter, Jörn Kekow, et al.
Rheumatology (Oxford, England)|November 21, 2019
Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritisMartin Schäfer, Yvette Meißner, Jörn Kekow, et al.
Arthritis Research & Therapy|January 13, 2010
Risk of incident or recurrent malignancies among patients with rheumatoid arthritis exposed to biologic therapy in the German biologics register RABBITAnja Strangfeld, Franka Hierse, Rolf Rau, et al.
Rheumatology (Oxford, England)|February 20, 2020
Corrigendum to: Obesity reduces the real-world effectiveness of cytokine-targeted but not cell-targeted disease-modifying agents in rheumatoid arthritisMartin Schäfer, Yvette Meißner, Jörn Kekow, et al.
Rheumatology (Oxford, England)|May 24, 2015
Health-related quality of life in patients with long-standing rheumatoid arthritis in the era of biologics: data from the German biologics register RABBITKerstin Gerhold, Adrian Richter, Matthias Schneider, et al.
Arthritis and Rheumatism|November 1, 2006
Effectiveness of tumor necrosis factor inhibitors in rheumatoid arthritis in an observational cohort study: comparison of patients according to their eligibility for major randomized clinical trialsAngela Zink, Anja Strangfeld, Matthias Schneider, et al.
Arthritis Research & Therapy|August 2, 2023
Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohortAndreas Reich, Anja Weiß, Lisa Lindner, et al.
Arthritis Research & Therapy|October 11, 2024
Correction: Depressive symptoms are associated with fatigue, poorer functional status and less engagement in sports in axSpA and PsA: an analysis from the RABBIT-SpA cohortAndreas Reich, Anja Weiß, Lisa Lindner, et al.
RMD Open|April 5, 2024
Impact of DMARD treatment and systemic inflammation on all-cause mortality in patients with rheumatoid arthritis and interstitial lung disease: a cohort study from the German RABBIT registerTatjana Rudi, Vera Zietemann, Yvette Meissner, et al.
Annals of the Rheumatic Diseases|April 28, 2021
EULAR COVID-19 registry: lessons learnt and future considerationsSaskia Lawson-Tovey, Anja Strangfeld, Kimme L Hyrich, et al.
Pageof 14